⌕
Immunovant · IMVT · Nasdaq
Tenet 35 · Weak
Compare
$33.28−2.63%At closeTenet 35 · Weak
$33.28−0.90 (−2.63%)
At close: Nov 16, 2026, 4:00 PM ET· Nasdaq · USD

Immunovant (IMVT) Stock Splits

Splits, dividend moves, buybacks and structural changes on file for IMVT, and what each one says about how management treats you, the shareholder.

Sources Dividend announcements and company filings Dividends and filingsHow we compute thisNot investment advice

1 figure withheld by our checks. Each blank figure names its reason.

•
Management posture
Returns cash, still building a record

Management returns cash through dividends and/or buybacks, but the track record is shorter or less consistent than a seasoned compounder's. Judge each action on its own coverage.

Annual raise streak
—
no dividend on file
Buyback · FY26
$504,000.00
repurchased, latest FY
Last split
None
no splits on file
Delist / distress
None
no red flags on file
No actions on file for this range.
Reads are interpretationsEach action's read is Tenet's plain-English interpretation of the action type: a starting point, not investment advice.

Reads are Tenet's plain-English interpretation of each action type, a starting point, not investment advice.

How much stock did Immunovant buy back last fiscal year?

Immunovant repurchased $504,000.00 of its own shares in fiscal 2026.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.